GLP-1 Medication Price Tracker: Every Drug Compared (March 2026)
The GLP-1 medication landscape has transformed dramatically in early 2026. Between new federal pricing agreements, manufacturer self-pay programs, and the launch of TrumpRx, patients have more affordable access points than ever before — but the pricing picture is also more complex than ever.
Quick Answer
- GLP-1 medication prices have dropped significantly in 2026, with self-pay options now ranging from $199-$499/month depending on medication and dose — down from $1,000+ list prices.
- Medicare patients pay a maximum $50/month copay for GLP-1 injectables like Wegovy and Zepbound under new federal pricing agreements, while Medicaid patients pay $0.
- The TrumpRx direct-to-consumer platform offers Ozempic, Wegovy, Mounjaro, and Zepbound at approximately $245-$350/month.
- Commercially insured patients can still access $25/month copay cards from both Novo Nordisk and Eli Lilly for qualifying prescriptions.
GLP-1 Medication Price Tracker: Every Drug Compared (March 2026)
The GLP-1 medication landscape has transformed dramatically in early 2026. Between new federal pricing agreements, manufacturer self-pay programs, and the launch of TrumpRx, patients have more affordable access points than ever before — but the pricing picture is also more complex than ever.
We tracked the current cost of every major GLP-1 medication across list price, self-pay, GoodRx, Medicare, and commercially insured channels. This is the most comprehensive GLP-1 pricing database available, updated for March 2026.
If you are new to GLP-1 medications, our complete beginner's guide explains how these drugs work and who qualifies.
Every GLP-1 Medication: March 2026 Price Comparison
Semaglutide Injectables (Novo Nordisk)
Ozempic (semaglutide, FDA-approved for type 2 diabetes)
| Pricing Channel | Monthly Cost | Notes |
|---|---|---|
| List Price | $998/month | Manufacturer list, rarely paid in practice |
| Self-Pay (NovoCare Pharmacy) | $349/month | All doses except 2mg; 2mg dose is $499/month |
| GoodRx Introductory | $199/month | First 2 fills for new users |
| GoodRx Ongoing | $299-$349/month | After introductory period |
| TrumpRx | ~$245/month | New federal pricing platform |
| Medicare Copay | $50/month max | Under new federal pricing agreements |
| Medicaid | $0 | Free under federal agreements (effective late 2025) |
| Commercial Insurance + Savings Card | As low as $25/month | NovoCare Savings Card required |
Wegovy (semaglutide, FDA-approved for weight management)
| Pricing Channel | Monthly Cost | Notes |
|---|---|---|
| List Price | $1,350/month | Manufacturer list price |
| Self-Pay (NovoCare Pharmacy) | $349/month | All dosages, reduced from $499 |
| Self-Pay Introductory | $199/month | First 2 months on 0.25mg or 0.5mg (before 3/31/26) |
| GoodRx Introductory | $199/month | First 2 fills for new users |
| GoodRx Ongoing | $349/month | After introductory period |
| TrumpRx | ~$245/month | New federal pricing platform |
| Medicare Copay | $50/month max | Under new federal pricing agreements |
| Medicaid | $0 | Free under federal agreements |
| Commercial Insurance + Savings Card | $0-$225 off/month | Eligible patients via NovoCare |
For a detailed comparison between the injection and the new oral formulation, see our Wegovy pill vs. injection analysis.
Rybelsus (semaglutide oral tablet, FDA-approved for type 2 diabetes)
| Pricing Channel | Monthly Cost | Notes |
|---|---|---|
| List Price | $997/month | 30-day supply |
| Self-Pay | $950-$1,100/month | Varies by pharmacy |
| GoodRx | $149/month | Introductory price for Wegovy pill formulation |
| TrumpRx | ~$245/month | Estimated pricing |
| Medicare Copay | $50/month max | Under new federal pricing agreements |
| Commercial Insurance + Savings Card | As low as $25/month | Via NovoCare |
Tirzepatide (Eli Lilly)
Mounjaro (tirzepatide, FDA-approved for type 2 diabetes)
| Pricing Channel | Monthly Cost | Notes |
|---|---|---|
| List Price | $1,069/month | Same price across all doses (2.5mg-15mg) |
| Self-Pay (LillyDirect) | $349-$499/month | Varies by dose |
| TrumpRx | ~$245/month | New federal pricing platform |
| Medicare Copay | $50/month max | Under new federal pricing agreements |
| Medicaid | $0 | Free under federal agreements |
| Commercial Insurance + Savings Card | As low as $25/month | Mounjaro Savings Card |
Zepbound (tirzepatide, FDA-approved for weight management)
| Pricing Channel | Monthly Cost | Notes |
|---|---|---|
| List Price | $1,086/month | Manufacturer list price |
| Self-Pay (LillyDirect) | $299-$449/month | $299 for 2.5mg, $399 for 5mg, $449 for 7.5mg-15mg |
| TrumpRx | ~$346/month | New federal pricing, down from $1,086 |
| Medicare Copay | $50/month max | Under new federal pricing agreements |
| Medicaid | $0 | Free under federal agreements |
| Commercial Insurance + Savings Card | As low as $25/month | For qualifying commercial plans |
Our semaglutide vs. tirzepatide comparison breaks down clinical efficacy differences between these two drug classes.
Liraglutide
Saxenda (liraglutide, FDA-approved for weight management)
| Pricing Channel | Monthly Cost | Notes |
|---|---|---|
| List Price | $1,349/month | 5 prefilled pens per 30-day supply |
| GoodRx | ~$900-$1,100/month | With GoodRx coupon |
| Generic Liraglutide | $470-$704/month | FDA-approved generic (August 2025), 2-3 pen packs |
| Commercial Insurance + Savings Card | Varies | Check Novo Nordisk savings programs |
Victoza (liraglutide, FDA-approved for type 2 diabetes)
| Pricing Channel | Monthly Cost | Notes |
|---|---|---|
| List Price | ~$1,100/month | Manufacturer list price |
| Generic Liraglutide | $470-$704/month | Generic version available since August 2025 |
| Commercial Insurance | Varies | Often covered as diabetes medication |
Other GLP-1 Medications
Trulicity (dulaglutide, Eli Lilly)
| Pricing Channel | Monthly Cost | Notes |
|---|---|---|
| List Price | ~$1,076/month | Weekly injection |
| GoodRx | ~$800-$950/month | With GoodRx coupon |
| Commercial Insurance | Varies | Often covered for type 2 diabetes |
Byetta/Bydureon (exenatide, AstraZeneca)
| Pricing Channel | Monthly Cost | Notes |
|---|---|---|
| List Price | ~$800-$900/month | Twice-daily (Byetta) or weekly (Bydureon) |
| GoodRx | ~$600-$750/month | With coupon |
| Generic | Not yet available | Patent protections still active |
Adlyxin (lixisenatide, Sanofi)
| Pricing Channel | Monthly Cost | Notes |
|---|---|---|
| List Price | ~$900/month | Once-daily injection |
| Availability | Limited | Discontinued in some markets |
The 2026 Price Revolution: What Changed
TrumpRx and Most-Favored-Nation Pricing
The biggest pricing shift of 2026 came from the White House's Most-Favored-Nation (MFN) pricing initiative, announced in November 2025. The program created TrumpRx (TrumpRx.gov), a direct-to-consumer platform that launched in early 2026 to connect patients with manufacturer discount programs. As of March 2026, injectable GLP-1 medications are available at approximately $350/month through TrumpRx, with oral Wegovy starting at $149/month. The platform that offers GLP-1 medications at significantly reduced prices:
- Medicare prices for Ozempic, Wegovy, Mounjaro, and Zepbound set at $245/month — less than half what the Biden Administration had proposed
- Medicare beneficiaries now have a $50/month maximum copay for GLP-1 injectables
- Medicaid patients pay $0 for GLP-1 injectables under new federal pricing agreements announced in late 2025
This represents the single largest reduction in GLP-1 medication costs since these drugs first launched. For patients who were previously paying $1,000+ per month out of pocket, the savings are transformative.
Manufacturer Self-Pay Programs
Both Novo Nordisk and Eli Lilly dramatically expanded their self-pay programs in response to federal pressure and the end of the compounded semaglutide shortage:
Novo Nordisk (January 2026):
- Reduced self-pay for Wegovy and most Ozempic doses from $499 to $349/month
- Launched $199/month introductory pricing for new Wegovy patients (first 2 months on starting doses)
- Expanded NovoCare Pharmacy as a direct-to-patient channel
Eli Lilly (February 2026):
- Launched Zepbound Self Pay Journey Program with tiered pricing from $299-$449/month
- Maintained single-dose vial options at lower price points than traditional pens
For more on compounded alternatives that are being affected by these changes, see our compounded semaglutide guide.
Generic Liraglutide
The FDA approved the first generic version of Saxenda (liraglutide) in August 2025, bringing weight-loss-dose liraglutide costs down to $470-$704/month. While still expensive compared to the new self-pay options for semaglutide and tirzepatide, generic liraglutide provides a lower-cost entry point for patients who respond well to this first-generation GLP-1.
How to Get the Lowest Price on GLP-1 Medications
Step 1: Check Your Insurance Coverage
If you have commercial insurance:
- For diabetes: Most plans cover Ozempic, Mounjaro, or Trulicity with varying copays. Ask your doctor about prior authorization.
- For weight management: Coverage for Wegovy and Zepbound varies widely. Plans are increasingly adding coverage as prices drop.
- Apply savings cards: Both Novo Nordisk and Eli Lilly offer copay cards that can reduce commercially insured costs to $25/month.
If you have Medicare:
- New in 2026: Medicare now covers GLP-1s for weight management (not just diabetes), with a $50/month maximum copay.
- Check TrumpRx: The new federal pricing platform offers the lowest Medicare pricing at approximately $245/month.
Read our GLP-1 Medicare coverage guide for step-by-step enrollment instructions.
If you have Medicaid:
- GLP-1 injectables are now $0 for Medicaid patients under federal pricing agreements announced in late 2025. Medicare coverage via the GLP-1 Bridge program begins July 2026 with a $50/month copay.
- Contact your state Medicaid office to confirm coverage and formulary status.
Step 2: Compare Self-Pay Options
If you are uninsured or your insurance does not cover GLP-1 medications:
- TrumpRx — ~$245-$350/month for major GLP-1s
- Manufacturer direct programs — $199-$499/month depending on medication and dose
- GoodRx — $149-$349/month with introductory and ongoing coupons
- Cost-plus pharmacies — Some pharmacies like Mark Cuban's Cost Plus Drugs are negotiating GLP-1 pricing
Step 3: Explore Patient Assistance Programs
Novo Nordisk Patient Assistance Program (PAP):
- Eligibility: Household income at or below 400% of federal poverty level (200% for Ozempic)
- Must have Medicare or no insurance (not available with commercial insurance)
- Provides medications at no cost to qualifying patients
- Apply at NovoCare.com or call 1-866-310-7549
Eli Lilly Cares:
- Important note: Zepbound is NOT currently available through Lilly Cares (as of March 2026)
- Mounjaro may be available for qualifying patients
- Income-based eligibility requirements
Step 4: Consider the Total Cost of GLP-1 Therapy
Beyond medication costs, factor in:
- Telehealth consultations: $29-$199/month depending on platform (see our best online GLP-1 programs ranking)
- Lab work: $50-$200 per blood panel, typically required quarterly
- Nutritional support: Optional but recommended (see our GLP-1 diet guide)
- Skin and muscle maintenance: Address Ozempic face and muscle loss prevention proactively
Price Trends: Where GLP-1 Costs Are Heading
Short-Term (2026)
The current pricing environment is the most favorable patients have ever experienced. Several factors are pushing prices lower:
- Federal pressure through MFN pricing and TrumpRx
- Competition between Novo Nordisk and Eli Lilly driving self-pay reductions
- Compounding pharmacies (while supplies last) offering alternatives at $100-$300/month
- Generic liraglutide establishing a lower price floor
Medium-Term (2027-2028)
Key factors to watch:
- Compounded semaglutide availability depends on FDA shortage declarations and ongoing litigation
- New entrants: Next-generation GLP-1 drugs from Amgen (MariTide), Pfizer (danuglipron), and Viking Therapeutics could increase competition
- Oral semaglutide for weight loss: Novo Nordisk's oral formulation could shift the market significantly
- Generic semaglutide timeline: The earliest generic semaglutide could arrive is 2031-2032, though patent challenges may accelerate this (see our generic semaglutide analysis)
Long-Term (2029+)
Industry analysts project GLP-1 medication prices will continue declining as:
- More competitors enter the market
- Patents expire and generics become available
- Government negotiation programs expand
- Global manufacturing capacity increases
Methodology and Data Sources
All prices in this tracker were verified as of March 15, 2026, using the following sources:
- List prices: Manufacturer pricing databases (Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi)
- Self-pay programs: NovoCare Pharmacy, LillyDirect, TrumpRx platform
- GoodRx pricing: GoodRx.com cash price estimates for major retail pharmacies
- Medicare/Medicaid: CMS pricing schedules and White House fact sheets
- Insurance copays: Based on manufacturer savings card terms and average commercial plan copays
Prices change frequently. We update this tracker monthly. Bookmark this page and check back for the latest data.
Frequently Asked Questions
What is the cheapest GLP-1 medication available in March 2026?
For Medicare patients, GLP-1 injectables now cost a maximum of $50/month in copays. For self-pay patients, GoodRx offers introductory pricing as low as $149/month for the Wegovy pill and $199/month for injectable semaglutide. The cheapest ongoing self-pay option is the Zepbound 2.5mg single-dose vial at $299/month through LillyDirect.
Does Medicare now cover GLP-1 medications for weight loss?
Yes. As of 2026, Medicare covers GLP-1 medications for weight management — not just type 2 diabetes. Medicare beneficiaries pay a maximum copay of $50/month for GLP-1 injectables like Wegovy and Zepbound under the new federal pricing agreements. Previously, Medicare only covered GLP-1s prescribed for diabetes.
What is TrumpRx and how does it reduce GLP-1 prices?
TrumpRx is a direct-to-consumer prescription platform launched as part of the White House's Most-Favored-Nation pricing initiative. It offers GLP-1 medications at approximately $245-$350/month, roughly 70% below manufacturer list prices. The platform negotiated pricing based on what these drugs cost in other developed countries, then passed those savings directly to patients.
Can I still get compounded semaglutide in 2026?
Compounded semaglutide availability in 2026 depends on FDA shortage declarations and ongoing legal disputes between compounding pharmacies and manufacturers. Some compounding pharmacies continue to offer semaglutide at $100-$300/month, but availability is inconsistent and may be limited by new regulations. Our compounded semaglutide guide tracks the latest legal status.
How do I qualify for a GLP-1 savings card?
Manufacturer savings cards from Novo Nordisk and Eli Lilly can reduce your copay to as low as $25/month, but they have specific eligibility requirements: you must have commercial insurance (not Medicare, Medicaid, or other government insurance), your plan must cover the specific medication, and you must have a valid prescription. Apply at NovoCare.com (for Ozempic/Wegovy) or LillyDirect.com (for Mounjaro/Zepbound).
Related Reading
- GLP-1 Medication Costs in 2026: Prices, Insurance, Medicare, and How to Save
- Best Online GLP-1 Programs in 2026: 8 Telehealth Platforms Ranked
- GLP-1 Side Effects: What to Expect and How to Manage Them
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. GLP-1 medications require a prescription and medical supervision. Always consult your healthcare provider before starting or changing any medication. Prices and availability are subject to change without notice.
Affiliate Disclosure: Some links in this article may be affiliate links. We may earn a commission if you make a purchase, at no additional cost to you. This does not influence our editorial content or pricing data.
-- The GLP-1 Daily Team
On Google
Get our answers in your Google results.
Add The GLP-1 Daily as a preferred source and Google will surface our reporting more often — in Top Stories and AI answers, marked with a preferred badge. One tap, free, undo anytime.
Add us as a preferred sourceOpens Google's source preferences for theglp1daily.com. No sign-up with us — it's a Google setting.